Free Access
Med Sci (Paris)
Volume 25, Number 6-7, Juin-Juillet 2009
Page(s) 622 - 626
Section M/S revues
Published online 15 June 2009
  1. Picot S. Is Plasmodium vivax still a paradigm for uncomplicated malaria ? Med Mal Infect 2006; 36 : 406–13. [Google Scholar]
  2. World Health Organization. Word Malaria Report 2008. Geneva : WHO, 2008. [Google Scholar]
  3. Picard J, Mills A. The effect of malaria on work time: analysis of data from two Nepali districts. J Trop Med Hyg 1992; 95 : 382–9. [Google Scholar]
  4. Mendis K, Sina BJ, Marchesini P, et al. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64 : 97–106. [Google Scholar]
  5. Hay SI, Guerra CA, Tatem AJ, et al. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004; 4 : 327–36. [Google Scholar]
  6. Carlton JM, Adams JH, Silva JC, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008; 455 : 757–63. [Google Scholar]
  7. Ntumngia FB, McHenry AM, Barnwell JW, et al. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am J Trop Med Hyg 2009; 80 : 218–27. [Google Scholar]
  8. Labie D. Polymorphismes de Plasmodium vivax. Comment les interpréter ? Quelles incidences en santé publique aujourd’hui ? Med Sci (Paris) 2005; 21 : 123–4. [Google Scholar]
  9. Collins WE, Sullivan JS, Jeffery GM, et al. The Chesson strain of Plasmodium vivax in humans and different species of Aotus monkeys. Am J Trop Med Hyg 2009; 80 : 152–9. [Google Scholar]
  10. White NJ. Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis 2008; 46 : 172–3. [Google Scholar]
  11. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008; 46 : 165–71. [Google Scholar]
  12. Oliver M, Simon F, de Monbrison F, et al. New use of primaquine for malaria. Med Mal Infect 2008; 38 : 169–79. [Google Scholar]
  13. Huldén L, Huldén L. Dynamics of positional warfare malaria: Finland and Korea compared. Malar J 2008; 7 :171. [Google Scholar]
  14. Chen N, Auliff A, Rieckmann K, et al. Relapses of Plasmodium vivax infection result from clonal hypnozoïtes activated at predetermined intervals. J Infect Dis 2007; 195 : 934–41. [Google Scholar]
  15. Alves FP, Durlacher RR, Menezes MJ, et al. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002; 66 : 641–8. [Google Scholar]
  16. Karunaweera ND, Wijesekera SK, Wanasekera D, et al. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 2003; 19 : 188–93. [Google Scholar]
  17. Elliott JH, O’Brien D, Leder K, et al. Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. J Travel Med 2004; 11 : 213–7. [Google Scholar]
  18. Mühlberger N, Jelinek T, Gascon J, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 2004; 8 : 3–5. [Google Scholar]
  19. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007; 77 : 984–91. [Google Scholar]
  20. Genton B, D’Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5 : 881–9. [Google Scholar]
  21. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5 : e128. [Google Scholar]
  22. Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 2009; 80 : 194–8. [Google Scholar]
  23. Tan LK, Yacoub S, Scott S, et al. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 2008; 8 : 449–54. [Google Scholar]
  24. Jiménez BC, Navarro M, Huerga H, et al. Spontaneous splenic rupture due to Plasmodium vivax in a traveler: case report and review. J Travel Med 2007; 14 : 188–91. [Google Scholar]
  25. Prakash J, Singh AK, Kumar NS, et al. Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India 2003; 51 : 265–7. [Google Scholar]
  26. Choi HJ, Lee SY, Yang H, et al. Retinal haemorrhages in vivax malaria. Trans R Soc Trop Med Hyg 2004; 98 : 387–9. [Google Scholar]
  27. Rodríguez-Morales AJ, Sánchez E, Vargas M, et al. Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? Am J Med 2006; 119 : e9–10. [Google Scholar]
  28. Obaldía N 3rd. Clinico-pathological observations on the pathogenesis of severe thrombocytopenia and anemia induced by Plasmodium vivax infections during antimalarial drug efficacy trials in Aotus monkeys. Am J Trop Med Hyg 2007; 77 : 3–13. [Google Scholar]
  29. Lawn SD, Krishna S, Jarvis JN, et al. Case reports: pernicious complications of benign tertian malaria. Trans R Soc Trop Med Hyg 2003; 97 : 551–3. [Google Scholar]
  30. Ozen M, Gungor S, Atambay M, et al. Cerebral malaria owing to Plasmodium vivax: case report. Ann Trop Paediat 2006; 26 : 141–4. [Google Scholar]
  31. Wickramasinghe SN, Looareesuwan S, Nagachinta B, et al. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol 1989; 72 : 91–9. [Google Scholar]
  32. Rodríguez-Morales AJ, Sánchez E, Vargas M, et al. Occurrence of thrombocytopenia in Plasmodium vivax malaria. Clin Infect Dis 2005; 41 : 130–1. [Google Scholar]
  33. Agarwal R, Nath A, Gupta D. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern Med 2007; 46 : 2007–11. [Google Scholar]
  34. Anstey NM, Handojo T, Pain MC, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 2007; 195 : 589–96. [Google Scholar]
  35. Marsden PD, Bruce-Chwatt LJ. Cerebral malaria. Contemp Neurol Ser 1975; 12 : 29–44. [Google Scholar]
  36. Beg MA, Khan R, Baig SM, et al. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 2002; 67 : 230–2. [Google Scholar]
  37. Kochar DK, Saxena V, Singh N, et al. Plasmodium vivax malaria. Emerg Infect Dis 2005; 11 : 132–4. [Google Scholar]
  38. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354 : 546–9. [Google Scholar]
  39. Hemmer CJ, Holst FG, Kern P, et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006; 11 : 817–23. [Google Scholar]
  40. Zeyrek FY, Kurcer MA, Zeyrek D, et al. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunol 2006; 28 : 201–7. [Google Scholar]
  41. Karunaweera N, Wanasekara D, Chandrasekharan V, et al. Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation. Malar J 2007; 6 : 62. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.